<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Des Devel Ther</journal-id><journal-id journal-id-type="iso-abbrev">Drug Des Devel Ther</journal-id><journal-title-group><journal-title>Drug Design, Development and Therapy</journal-title></journal-title-group><issn pub-type="epub">1177-8881</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3634318</article-id><article-id pub-id-type="doi">10.2147/DDDT.S46202</article-id><article-id pub-id-type="publisher-id">dddt-7-349</article-id><article-categories><subj-group subj-group-type="heading"><subject>Corrigendum</subject></subj-group></article-categories><title-group><article-title>Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial [Corrigendum]</article-title></title-group><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>17</day><month>4</month><year>2013</year></pub-date><volume>7</volume><fpage>349</fpage><lpage>349</lpage><permissions><copyright-statement>&#x000a9; 2013 Takami and Saito, publisher and licensee Dove Medical Press Ltd.</copyright-statement><copyright-year>2013</copyright-year><license><license-p>This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.</license-p></license></permissions></article-meta></front><body><p><related-article related-article-type="corrected-article" id="d35e51" vol="7" page="175" ext-link-type="pmc">Takami T, Saito Y. <italic>Drug Design, Development and Therapy</italic>. 2013;7:175&#x02013;183.</related-article></p><p>On page 177, line 26, heading &#x0201c;Measurement of LVMI and LF diastolic function&#x0201d; should have been &#x0201c;Measurement of LVMI and LV diastolic function&#x0201d;. Line 32, &#x0201c;Devereux et al<sup>18</sup>&#x0201d; should read &#x0201c;Devereux et al<sup>19</sup>&#x0201d;. Line 40, &#x0201c;(E/e&#x02019; ratio) were measured as previously described.<sup>19</sup>&#x0201d; should read &#x0201c;(E/e&#x02019; ratio) were measured as previously described.<sup>20</sup>&#x0201d;.</p><p>On page 181, line 15, &#x0201c;baPWV with LVMI.<sup>20</sup>&#x0201d; should read &#x0201c;baPWV with LVMI.<sup>21</sup>&#x0201d;. Line 23, &#x0201c;baPWV and LVMI, E/A ratio.<sup>20</sup>&#x0201d; should read &#x0201c;baPWV and LVMI, E/A ratio.<sup>21,22</sup>&#x0201d;. Line 28 &#x0201c;diastolic dysfunction.<sup>21</sup>&#x0201d; should read &#x0201c;diastolic dysfunction.<sup>23</sup>&#x0201d;. Line 38 &#x0201c;is high.<sup>22</sup>&#x0201d; should read &#x0201c;is high.<sup>24</sup>&#x0201d;. Line 39, &#x0201c;in clinical treatment.<sup>23</sup>&#x0201d; should read &#x0201c;in clinical treatment.<sup>25</sup>&#x0201d;. Line 57, &#x0201c;A recent cohort study<sup>24</sup>&#x0201d; should read &#x0201c;A recent cohort study<sup>21</sup>&#x0201d;.</p><p>On page 182, line 1, &#x0201c;diastolic heart failure.<sup>25</sup>&#x0201d; should read &#x0201c;diastolic heart failure.<sup>26</sup>&#x0201d;. Line 3, &#x0201c;untreated hypertensive patients.<sup>26</sup>&#x0201d; should read &#x0201c;untreated hypertensive patients.<sup>27</sup>&#x0201d;. Line 6, &#x0201c;linear regression analysis.<sup>27</sup>&#x0201d; should read &#x0201c;linear regression analysis.<sup>21</sup>&#x0201d;.</p><p>On page 183, the references 18 to 27 should be updated as shown below:</p><list list-type="simple"><list-item><p>18. Takami T. Evaluation of arterial stiffness in morning hypertension under high-dose valsartan compared to valsartan plus low-dose diuretic. <italic>Hypertens Res</italic>. 2009;32:1086&#x02013;1090.</p></list-item><list-item><p>19. Devereux RB, Palmieri V, Sharpe N, et al. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (PRESERVE) trial. <italic>Circulation</italic>. 2001;104:1248&#x02013;1254.</p></list-item><list-item><p>20. Ito H, Ishii K, Kihara H, et al. Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension. <italic>Hypertens Res</italic>. 2012;35:93&#x02013;99.</p></list-item><list-item><p>21. Xu L, Jiang CQ, Lam TH, et al. Arterial stiffness and left-ventricular diastolic dysfunction: Guangzhou Biobank Cohort Study-CVD. <italic>J Hum Hypertens</italic>. 2011;25:152&#x02013;158.</p></list-item><list-item><p>22. Kim MN, Park SM, Shim WJ, et al. The relationship between aortic stiffness and left ventricular dyssynchrony in hypertensive patients with preserved left ventricular systolic function. <italic>Clin Exp Hypertens</italic>. 2012;34:410&#x02013;416.</p></list-item><list-item><p>23. Schillaci G, Pasqualini L, Verdecchia P, et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. <italic>J Am Coll Cardiol</italic>. 2002;39:2005&#x02013;2011.</p></list-item><list-item><p>24. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. <italic>Circulation</italic>. 2000;102:1788&#x02013;1794.</p></list-item><list-item><p>25. Hillis GS, M&#x000f8;ller JE, Pellikka PA, et al. Noninvasive estimation of left ventricular filling pressure by e/&#x000e9; is a powerful predictor of survival after acute myocardial infarction. <italic>J Am Coll Cardiol</italic>. 2004;43:360&#x02013;367.</p></list-item><list-item><p>26. Yambe M, Tomiyama H, Hirayama Y, et al. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. <italic>Hypertens Res</italic>. 2004;27:625&#x02013;631.</p></list-item><list-item><p>27. Jaroch J, &#x00141;oboz Grudzie&#x00144; K, Boci&#x00105;ga Z, et al. The relationship of carotid arterial stiffness to left ventricular diastolic dysfunction in untreated hypertension. <italic>Kardiol Pol</italic>. 2012;70:223&#x02013;231.</p></list-item></list></body></article>